Stimulation of bone formation by monocyte-activator functionalized graphene oxide in vivo.


Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
07 Nov 2019
Historique:
pubmed: 7 8 2019
medline: 7 3 2020
entrez: 7 8 2019
Statut: ppublish

Résumé

Nanosystems are able to enhance bone regeneration, a complex process requiring the mutual interplay between immune and skeletal cells. Activated monocytes can communicate pro-osteogenic signals to mesenchymal stem cells and promote osteogenesis. Thus, the activation of monocytes is a promising strategy to improve bone regeneration. Nanomaterials specifically selected to provoke immune-mediated bone formation are still missing. As a proof of concept, we apply here the intrinsic immune-characteristics of graphene oxide (GO) with the well-recognized osteoinductive capacity of calcium phosphate (CaP) in a biocompatible nanomaterial called maGO-CaP (monocytes activator GO complexed with CaP). In the presence of monocytes, the alkaline phosphatase activity and the expression of osteogenic markers increased. Studying the mechanisms of action, we detected an up-regulation of Wnt and BMP signaling, two key osteogenic pathways. The role of the immune activation was evidenced by the over-production of oncostatin M, a pro-osteogenic factor produced by monocytes. Finally, we tested the pro-osteogenic effects of maGO-CaP in vivo. maGO-CaP injected into the tibia of mice enhanced local bone mass and the bone formation rate. Our study suggests that maGO-CaP can activate monocytes to enhance osteogenesis ex vivo and in vivo.

Identifiants

pubmed: 31386739
doi: 10.1039/c9nr03975a
doi:

Substances chimiques

Biocompatible Materials 0
Bone Morphogenetic Protein 2 0
Calcium Phosphates 0
Wnt Proteins 0
graphene oxide 0
Oncostatin M 106956-32-5
Graphite 7782-42-5
calcium phosphate 97Z1WI3NDX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19408-19421

Auteurs

Valentina Bordoni (V)

University of Sassari, Sassari, Italy. lgdelogu@uniss.it.

Giacomo Reina (G)

University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572 Strasbourg, France. a.bianco@ibmc-cnrs.unistra.fr.

Marco Orecchioni (M)

University of Sassari, Sassari, Italy. lgdelogu@uniss.it.

Giulia Furesi (G)

University of Sassari, Sassari, Italy. lgdelogu@uniss.it and TU Dresden Medical Center, Dresden, Germany. Martina.Rauner@uniklinikum-dresden.de.

Stefanie Thiele (S)

TU Dresden Medical Center, Dresden, Germany. Martina.Rauner@uniklinikum-dresden.de.

Chiara Gardin (C)

Department of Biomedical Sciences University of Padova, Padova, Italy.

Barbara Zavan (B)

Department of Biomedical Sciences University of Padova, Padova, Italy.

Gianaurelio Cuniberti (G)

Max Bergmann Center of Biomaterials and Institute for Materials Science, Dresden University of Technology, Dresden, Germany.

Alberto Bianco (A)

University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572 Strasbourg, France. a.bianco@ibmc-cnrs.unistra.fr.

Martina Rauner (M)

TU Dresden Medical Center, Dresden, Germany. Martina.Rauner@uniklinikum-dresden.de.

Lucia G Delogu (LG)

University of Sassari, Sassari, Italy. lgdelogu@uniss.it and Department of Biomedical Sciences, University of Padova, Padova, Italy and Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH